Alnylam Pharmaceuticals
ALNY
ALNY
472 hedge funds and large institutions have $24B invested in Alnylam Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 169 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
472
Holders Change
-11
Holders Change %
-2.28%
% of All Funds
7.55%
Holding in Top 10
5
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-64.29%
% of All Funds
0.08%
New
54
Increased
170
Reduced
169
Closed
54
Calls
$194M
Puts
$159M
Net Calls
+$34.8M
Net Calls Change
-$48M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$322M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$102M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$93.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$93.1M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$54.1M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$154M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$139M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$125M |
| 4 |
Holocene Advisors
New York
|
-$116M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$73.8M |
